GlassScriptPhysician profile
Chirag G Patil
NPI 1104006832
$30,652.82
in general payments reported to CMS, 2019-2025
11 companies · $30K in 2025
The $30K reported for 2025 was more than what 92% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $74.18 · 2021: $44.69 · 2022: $212 · 2023: $140 · 2024: $19.47 · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Travel and Lodging: $1,662 · Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,000.00 |
| Travel and Lodging | $1,662.28 |
| Food and Beverage | $347.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Digital Surgery Systems, INC. | $19,692.07 | 2025 | Aesculap |
| Koh Young America, INC. | $10,000.00 | 2025 | Geniant Cranial |
| Insightec,INC | $259.42 | 2022-2023 | Exablate |
| Stryker Corporation | $220.86 | 2019-2025 | Universal Neuro 3 |
| Monteris Medical Corporation | $213.65 | 2019-2023 | Neuroblate |
| Medtronic USA, INC. | $82.44 | 2019 | |
| Carbofix Spine INC | $74.18 | 2020 | |
| Abbott Laboratories | $52.27 | 2019-2023 | Infinity |
| Medtronic, INC. | $38.46 | 2025 | Percept PC Brainsense |
| Gt Medical Technologies, INC | $19.47 | 2024 | Gammatile |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chirag Patil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.